The most common liver tumor is hepatocellular
carcinoma (HCC) accounting for 80% of total primary tumors followed by cholangiocarcinoma4.
In terms of effect on the prevalence of hepatocellular
carcinoma (HCC), the modeling suggested cases of HCV-related liver cancer were predicted to peak at around 29,000 cases in 2025.
REACH-2 was a global, randomised, double-blind, placebo-controlled Phase three study of CYRAMZA compared to placebo in patients with hepatocellular
carcinoma who have been treated with sorafenib and are considered AFP-High.
Following the US FDA approval, LSK BioPharma will evaluate the safety and efficacy of its rivoceranib in combination with Hengrui's camrelizumab (SHR-1210) in the US in first-line patients with advanced hepatocellular
Compared with no treatment, DAA therapy cut risk of hepatocellular
carcinoma by about one-third and all-cause mortality by about half in the study, which included about 10,000 adult patients with chronic hepatitis C virus (HCV) infection treated at 1 of 32 hepatology centers in France (NCT01953458).
carcinoma (HCC) is one of the leading causes of death from cancer worldwide.1 In the United States, it has emerged to be the fastest growing cause of mortality in cancer patients.2 The presence of liver cirrhosis has been attributed to the development of hepatocellular
carcinoma.3 Chronic infections with HBV and HCV leading to fibrosis have been identified as the major contributors of HCC.4 With the development of HBV vaccine, a significant decline in HBV related HCC cases has been observed5 but the cases related to HCV are on a rise.
carcinoma (HCC) accounts for one-fifth of the most common cancers worldwide.
Increased incidence of bone metastasis in hepatocellular
(15) Bile production is frequently seen, confirming the tumor's hepatocellular
Stereotactic ablative radiotherapy (SABR) has been used to treat hepatocellular
carcinoma (HCC) with minimal toxicity and sustained local control (LC).
C-arm CT for assessing initial failure of iodized oil accumulation in chemoembolization of hepatocellular
Following a lifetime of dedicated investigation and study, his comprehensive contributions to the understanding of the epidemiology, biology and mechanisms of hepatocellular
cancer are legendary and unparalleled.